جمعه 15 فروردین 1404
[Archive]
دوره 30، شماره 143 - ( 7-1401 )
جلد 30 شماره 143 صفحات 485-477 |
برگشت به فهرست نسخه ها
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Mirzaei S, Hushmandi K, Entezari M, Bahonar A, Raei M, Akbari M E. Mesenchymal Stem Cells Trigger Epithelial to Mesenchymal Transition in the HT-29 Colorectal Cancer Cell Line. J Adv Med Biomed Res 2022; 30 (143) :477-485
URL: http://journal.zums.ac.ir/article-1-6459-fa.html
URL: http://journal.zums.ac.ir/article-1-6459-fa.html
Mesenchymal Stem Cells Trigger Epithelial to Mesenchymal Transition in the HT-29 Colorectal Cancer Cell Line. Journal of Advances in Medical and Biomedical Research. 1401; 30 (143) :477-485
چکیده: (30798 مشاهده)
Background and Objective: Mesenchymal stem cells (MSCs) promote metastasis in colorectal cancer; however, the mechanism underlying this process is not fully understood. Epithelial to mesenchymal transition (EMT) is a key step in tumor acquisition of metastatic phenotype. We aimed to investigate the effect of MSCs on the expression of EMT markers, as well as cancer stem cell markers in HT-29 colorectal cancer cells.
Materials and Methods: MSCs were isolated from bone marrow tissue, and their multi potency was confirmed. The HT-29 cell line was prepared and co-cultured with MSCs for 3 days using 6-well transwell co-culture plates (membrane pore size: 0.4 µm). Cell morphology was observed by inverted microscopy. The expression levels of EMT-related genes, namely E-cadherin, Vimentin, and β-catenin, were investigated by the RT-qPCR method. Also, the surface expression levels of CD44 and CD133 cancer stem cell markers were analyzed by flow cytometry.
Results: The co-culture of HT-29 cells with bone marrow-derived MSCs resulted in changes in cell morphology from epithelial to mesenchymal forms. The expression of mesenchymal stem cell markers, namely Vimentin and β-catenin, were significantly increased (2.25 and 1.83 folds, respectively), while the expression of the epithelial marker, E-cadherin, was reduced (0.3 folds). The expression of CD133 was also increased (51.5%).
Conclusion: Tumor-resident mesenchymal stem cells can promote colorectal cancer metastasis inducing EMT as well as increasing cancer stem cell frequency in the tumor microenvironment. It seems that direct contact between MSCs and colorectal cancer cells is not required for the interaction. Our findings may help scientists to find effective strategies against cancer metastasis by targeting tumor-resident MSCs.
نوع مطالعه: مقاله پژوهشی |
موضوع مقاله:
Medical Biology
دریافت: 1399/12/12 | پذیرش: 1400/7/28 | انتشار: 1401/7/18
دریافت: 1399/12/12 | پذیرش: 1400/7/28 | انتشار: 1401/7/18
فهرست منابع
1. Xie YH, Chen YX, Fang JY. Comprehensive review of targeted therapy for colorectal cancer. Signal Transduc Target Ther. 2020;5(1):1-30. [DOI:10.1038/s41392-020-0116-z] [PMID] [PMCID]
2. Ouladan S, Gregorieff A. Taking a step back: Insights into the mechanisms regulating gut epithelial dedifferentiation. Int J Molec Sci. 2021;22(13):7043. [DOI:10.3390/ijms22137043] [PMID] [PMCID]
3. Rawla P, Sunkara T, Barsouk A. Epidemiology of colorectal cancer: incidence, mortality, survival, and risk factors. Prz Gastroenterol. 2019; 14 (2): 89-103. [DOI:10.5114/pg.2018.81072] [PMID] [PMCID]
4. Barker N, Ridgway R, Van Es J, et al. Crypt stem cells as the cells-of-origin of intestinal cancer. Nature. 2009;457(7229):608-11. [DOI:10.1038/nature07602] [PMID]
5. Pang R, Law WL, Chu AC, et al. A subpopulation of CD26+ cancer stem cells with metastatic capacity in human colorectal cancer. Cell Stem Cell. 2010;6(6):603-15. [DOI:10.1016/j.stem.2010.04.001] [PMID]
6. Sahlberg SH, Spiegelberg D, Glimelius B, Stenerlöw B, Nestor M. Evaluation of cancer stem cell markers CD133, CD44, CD24: association with AKT isoforms and radiation resistance in colon cancer cells. PloS one. 2014;9(4):e94621. [DOI:10.1371/journal.pone.0094621] [PMID] [PMCID]
7. Ricci-Vitiani L, Lombardi DG, Pilozzi E, et al. Identification and expansion of human colon-cancer-initiating cells. Nature. 2007;445(7123):111-5. [DOI:10.1038/nature05384] [PMID]
8. Shi Y, Du L, Lin L, Wang Y. Tumour-associated mesenchymal stem/stromal cells: emerging therapeutic targets. Nat Rev Drug Discov. 2017;16(1):35-52. [DOI:10.1038/nrd.2016.193] [PMID]
9. Galland S, Stamenkovic I. Mesenchymal stromal cells in cancer: a review of their immunomodulatory functions and dual effects on tumor progression. J Pathol. 2020;250(5):555-72. [DOI:10.1002/path.5357] [PMID] [PMCID]
10. Hill BS, Pelagalli A, Passaro N, Zannetti A. Tumor-educated mesenchymal stem cells promote pro-metastatic phenotype. Oncotarget. 2017;8(42):73296. [DOI:10.18632/oncotarget.20265] [PMID] [PMCID]
11. Yu X, Odenthal M, Fries JW. Exosomes as miRNA carriers: formation-function-future. Int J Molec Sci. 2016;17(12):2028. [DOI:10.3390/ijms17122028] [PMID] [PMCID]
12. Cao H, Xu E, Liu H, Wan L, Lai M. Epithelial-mesenchymal transition in colorectal cancer metastasis: a system review. Pathol Res Pract. 2015;211(8):557-69. [DOI:10.1016/j.prp.2015.05.010] [PMID]
13. Micalizzi DS, Farabaugh SM, Ford HL. Epithelial-mesenchymal transition in cancer: parallels between normal development and tumor progression. J Mammary Gland Biol Neoplasia. 2010;15(2):117-34. [DOI:10.1007/s10911-010-9178-9] [PMID] [PMCID]
14. Caterson EJ, Nesti LJ, Danielson KG, Tuan RS. Human marrow-derived mesenchymal progenitor cells. Molec Biotechnol. 2002;20(3):245-56. [DOI:10.1385/MB:20:3:245]
15. Li P, Gong Z, Shultz LD, Ren G. Mesenchymal stem cells: from regeneration to cancer. Pharmacol & Therapeut. 2019;200:42-54. [DOI:10.1016/j.pharmthera.2019.04.005] [PMID] [PMCID]
16. Wang S, Miao Z, Yang Q, Wang Y, Zhang J. The dynamic roles of mesenchymal stem cells in colon cancer. Canadian J Gastroenterol Hepatol. 2018;2018. [DOI:10.1155/2018/7628763] [PMID] [PMCID]
17. Pelagalli A, Nardelli A, Fontanella R, Zannetti A. Inhibition of AQP1 hampers osteosarcoma and hepatocellular carcinoma progression mediated by bone marrow-derived mesenchymal stem cells. Int J Molec Sci. 2016;17(7):1102. [DOI:10.3390/ijms17071102] [PMID] [PMCID]
18. Shinagawa K, Kitadai Y, Tanaka M, et al. Mesenchymal stem cells enhance growth and metastasis of colon cancer. Int J Cancer. 2010;127(10):2323-33. [DOI:10.1002/ijc.25440] [PMID]
19. Takigawa H, Kitadai Y, Shinagawa K, et al. Multikinase inhibitor regorafenib inhibits the growth and metastasis of colon cancer with abundant stroma. Cancer Sci. 2016;107(5):601-8. [DOI:10.1111/cas.12907] [PMID] [PMCID]
20. Zhu W, Xu W, Jiang R, et al. Mesenchymal stem cells derived from bone marrow favor tumor cell growth in vivo. Experiment Molec Pathol. 2006;80(3):267-74. [DOI:10.1016/j.yexmp.2005.07.004] [PMID]
21. Klopp AH, Gupta A, Spaeth E, Andreeff M, Marini III F. Concise review: dissecting a discrepancy in the literature: do mesenchymal stem cells support or suppress tumor growth? Stem Cells. 2011;29(1):11-9. [DOI:10.1002/stem.559] [PMID] [PMCID]
22. Beckermann B, Kallifatidis G, Groth A, et al. VEGF expression by mesenchymal stem cells contributes to angiogenesis in pancreatic carcinoma. Br J Cancer. 2008;99(4):622-31. [DOI:10.1038/sj.bjc.6604508] [PMID] [PMCID]
23. Shin S, Lee J, Kwon Y, et al. Comparative proteomic analysis of the mesenchymal stem cells secretome from adipose, bone marrow, placenta and wharton's jelly. Int J Molec Sci. 2021;22(2):845. [DOI:10.3390/ijms22020845] [PMID] [PMCID]
24. Murphy SV, Atala A. Amniotic fluid stem cells. In:Cetrulo KJ,Cetrulo CL,TaghizadehRR,editors.Perinatal Stem Cells 2nd ed Hoboken, NJ: Wiley‐Blackwell. 2013.p:301 [DOI:10.1002/9781118497883.ch1]
25. Cortini M, Avnet S, Baldini N. Mesenchymal stroma: role in osteosarcoma progression. Cancer Lett. 2017;405:90-9. [DOI:10.1016/j.canlet.2017.07.024] [PMID]
26. Mathivanan S, Ji H, Simpson RJ. Exosomes: extracellular organelles important in intercellular communication. J Proteomic. 2010;73(10):1907-20. [DOI:10.1016/j.jprot.2010.06.006] [PMID]
27. Takigawa H, Kitadai Y, Shinagawa K, et al. Mesenchymal stem cells induce epithelial to mesenchymal transition in colon cancer cells through direct cell-to-cell contact. Neoplasia. 2017;19(5):429-38. [DOI:10.1016/j.neo.2017.02.010] [PMID] [PMCID]
28. Avnet S, Lemma S, Cortini M, Di Pompo G, Perut F, Baldini N. Pre-clinical models for studying the interaction between mesenchymal stromal cells and cancer cells and the induction of stemness. Front Oncol. 2019;9:305. [DOI:10.3389/fonc.2019.00305] [PMID] [PMCID]
29. Lin SP, Lee YT, Yang SH, et al. Colon cancer stem cells resist antiangiogenesis therapy-induced apoptosis. Cancer lett. 2013;328(2):226-34. [DOI:10.1016/j.canlet.2012.08.036] [PMID]
30. Huang EH, Hynes MJ, Zhang T, et al. Aldehyde dehydrogenase 1 is a marker for normal and malignant human colonic stem cells (SC) and tracks SC overpopulation during colon tumorigenesis. Cancer Res. 2009;69(8):3382-9. [DOI:10.1158/0008-5472.CAN-08-4418] [PMID] [PMCID]
31. Chen S, Song X, Chen Z, et al. CD133 expression and the prognosis of colorectal cancer: a systematic review and meta-analysis. PloS one. 2013;8(2):e56380. [DOI:10.1371/journal.pone.0056380] [PMID] [PMCID]
32. Pino MS, Kikuchi H, Zeng M, et al. Epithelial to mesenchymal transition is impaired in colon cancer cells with microsatellite instability. Gastroenterol. 2010;138(4):1406-17. [DOI:10.1053/j.gastro.2009.12.010] [PMID] [PMCID]
33. Camerlingo R, Miceli R, Marra L, et al. Conditioned medium of primary lung cancer cells induces EMT in A549 lung cancer cell line by TGF-ß1 and miRNA21 cooperation. PloS one. 2019;14(7):e0219597. [DOI:10.1371/journal.pone.0219597] [PMID] [PMCID]
34. Zhang X, Hu F, Li G, et al. Human colorectal cancer-derived mesenchymal stem cells promote colorectal cancer progression through IL-6/JAK2/STAT3 signaling. Cell Death Dis. 2018;9(2):1-13. [DOI:10.1038/s41419-017-0176-3] [PMID] [PMCID]
35. Martin F, Dwyer RM, Kelly J, et al. Potential role of mesenchymal stem cells (MSCs) in the breast tumour microenvironment: stimulation of epithelial to mesenchymal transition (EMT). Breast Cancer Res Treat. 2010;124(2):317-26. [DOI:10.1007/s10549-010-0734-1] [PMID]
36. Azizi P, Mazhari S, Tokhanbigli S, et al. Paracrine signals of mesenchymal stem cells induce epithelial to mesenchymal transition in gastric cancer cells. Gastroenterol Hepatol Bed Bench. 2019;12(Suppl1):S51.
37. Tsai JH, Yang J. Epithelial-mesenchymal plasticity in carcinoma metastasis. Genes Dev. 2013;27(20):2192-206. [DOI:10.1101/gad.225334.113] [PMID] [PMCID]
38. Vu T, Datta PK. Regulation of EMT in colorectal cancer: a culprit in metastasis. Cancers. 2017;9(12):171. [DOI:10.3390/cancers9120171] [PMID] [PMCID]
| بازنشر اطلاعات | |
 |
این مقاله تحت شرایط Creative Commons Attribution-NonCommercial 4.0 International License قابل بازنشر است. |
